US FDA standardizes stability testing of generic drugs by adopting ICH guides
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has standardized its policy on stability testing of generic drugs by adopting related guidelines developed by the International Conference on Harmonisation for new drug products1,2.